Enter your login e-mail to the account
Search
Search parameters
Search results
- Inflammatory myofibroblastic tumor
MUDr. Veronika Marcinakova, MUDr. Hana Dittrichova, MUDr. Karel Franěk, MUDr. Pavel Hanek
(1/2019, Communication from practice )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - News in the treatment of lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Review articles ) - 13th Central European Lung Cancer Conference, Praha, 24. – 27. 6. 2012
doc. MUDr. Peter Beržinec, CSc.
(4/2012, Events ) - The pathologist´s contribution for a targeted biological therapy of neoplastic disorders
prof. MUDr. Lukáš Plank, CSc.
(1/2011, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - NEW „MARKERS AND PROGNOSTIC FACTORS“ – THE SURGICAL PATHOLOGIST‘S VIEW
prof. MUDr. Štefan Galbavý, CSc.
(3/2006, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Cytogenetic and molecular cytogenetic methods in hemato-oncology
Mgr. Petra Nováková, MUDr. Denisa Ilenčíková, PhD.
(2/2010, Review articles ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Effective treatment of lung adenocarcinoma with target therapy – case report
MUDr. Gabriela Chowaniecová
(5/2017, Original articles & case reports ) - Targeted treatment of non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(4/2022, Review articles ) - Testing molecular biomarkers in the treatment and management of patients with lung cancer in Slovakia
RNDr. Regína Lohajová Behulová, PhD., RNDr. Romana Valenčíková, PhD., Dr. Med. Veronika Urbán
(S2/2023, Review articles ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Publikujeme v zahraničí
redakcia
(3/2018, Information & comments ) - The treatment of ALK-positive NSCLC ceritinib – view panel of experts Purpose: To find out the opinion of the Panel of experts on the effectiveness and
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan
(6/2015, Information & comments ) - Lung cancer molecular testing in Slovak Republic – view clinical practise
doc. MUDr. Peter Beržinec, CSc., MUDr. Peter Kasan, MUDr. Andrea Cipková, MPH., MUDr. Mária Černá, CSc., MUDr. Róbert Godál, MUDr. Gabriela Chowaniecová, MUDr. Igor Andrašina, CSc.
(6/2015, Main topic ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Diffuse large B-cell lymphoma in atypical locations
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2015, Spectrum ) - Particularities of non-Hodgkin´s lymphomas in children
MUDr. Ladislav Deák
(1/2016, Main topic ) - Molecular pathology of diffuse large B-cell lymphoma – a review
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD., MUDr. Jozef Mičák
(2/2015, Spectrum ) - Biology of malignant lymphomas
prof. MUDr. Lukáš Plank, CSc., MUDr. Tomáš Balhárek, PhD.
(2/2014, Main topic ) - Actual therapeutic strategy of patients with non small cell lung cancer with EML4-ALK rearrangement
MUDr. Juraj Mazal, MUDr. Michal Urda, RNDr. Anna Farkašová, PhD.
(1/2017, Review articles ) - Chronic lymphocytic leukaemia (editorial)
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2014, Oncohematology Review )
- Pharmacogenetics in practice of a clinical pharmacologist and a pharmacist
MUDr. Olga Bartošová, Ph.D., Prof. MUDr. Ondřej Slanař, Ph.D., PharmDr. Irena Netíková, Ph.D.
(3/2016, Clinical pharmacy )